EGFR and head and neck squamous cell carcinoma: The appearance of DM in HNSCC remains a challenge for several reasons: the treatment options of DM patients are still limited to chemotherapy, target therapy with epidermal growth factor receptor (EGFR) inhibitors, and immunotherapy [21], life expectancy is dramatically decreased, and quality of life is poor.